(Q36572712)

15 August 2017

1 reference

title

Hypertension and oxidative stress (English)

1 reference

15 August 2017

1 reference

Natalie C Ward

1 reference

15 August 2017

Kevin D Croft

series ordinal

1 reference

15 August 2017

language of work or name

1 reference

1 September 2006

1 reference

Clinical and Experimental Pharmacology and Physiology

15 August 2017

published in

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

page(s)

872-876

1 reference

Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Endothelial function in hypertension: the role of superoxide anion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Beyond blood pressure: the endothelium and atherosclerosis progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Role of cytochrome P450 metabolites of arachidonic acid in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Supplementation with tetrahydrobiopterin prevents the cardiovascular effects of angiotensin II-induced oxidative and nitrosative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Increased renal medullary oxidative stress produces hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

The anti-oxidant Tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Strategies to reduce oxidative stress in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Implications of Oxidative Stress and Homocysteine in the Pathophysiology of Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Antioxidant vitamin supplements and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Combination oral antioxidant supplementation reduces blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Does vitamin C reduce blood pressure? Results of a large study of people aged 65 or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Serum antioxidant vitamins and blood pressure in the United States population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Lack of long-term effect of vitamin C supplementation on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Vitamin E modulation of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Different effect of antihypertensive drugs on conduit artery endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04457.X

10.1111/J.1440-1681.2006.04457.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference